SMYD3 and hepatocellular carcinoma: Wang et al. (2021) identified four genes (CYP26A1, FAM110C, SMYD3, and ZG16) that were expected to be novel diagnostic and prognostic targets for HBV-related hepatocellular carcinoma (HCC).